Esperion Therapeutics
ESPR
#6736
Rank
โ‚ฌ0.46 B
Marketcap
2,36ย โ‚ฌ
Share price
2.49%
Change (1 day)
116.33%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -โ‚ฌ37.63 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.27 Billion. In 2023 the company made an earning of -โ‚ฌ0.15 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ37.63 Million-73.77%
2023 -โ‚ฌ0.15 Billion-15.03%
2022 -โ‚ฌ0.17 Billion-20.61%
2021 -โ‚ฌ0.22 Billion84.28%
2020 -โ‚ฌ0.12 Billion35.75%
2019 -โ‚ฌ85.01 Million-55.71%
2018 -โ‚ฌ0.2 Billion19.57%
2017 -โ‚ฌ0.17 Billion125.39%
2016 -โ‚ฌ71.22 Million51.43%
2015 -โ‚ฌ47.03 Million36.45%
2014 -โ‚ฌ34.47 Million43.55%
2013 -โ‚ฌ24.01 Million145.26%
2012 -โ‚ฌ9.79 Million
2002 -โ‚ฌ27.91 Million-7.81%
2001 -โ‚ฌ30.28 Million15.03%
2000 -โ‚ฌ26.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.5 Billion 1,177.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.37 B-1,061.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ1.16 Billion 2,878.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.74 B-12,310.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ95.31 Million 145.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.2 Billion 396.60%๐Ÿ‡บ๐Ÿ‡ธ USA